5-Bromo-2-acetylsalicylic acid → Acetoxy-5-bromo-N-{4-[(1,1-dimethyl)ethyl]thiazol-2-yl}benzamide
Reaktionsgleichung
[C:1]([O:4][C:5]1[CH:13]=[CH:12][C:11]([Br:14])=[CH:10][C:6]=1[C:7]([OH:9])=O)(=[O:3])[CH3:2].[NH2:15][C:16]1[S:17][CH:18]=[C:19]([C:21]([CH3:24])([CH3:23])[CH3:22])[N:20]=1>>[C:1]([O:4][C:5]1[CH:13]=[CH:12][C:11]([Br:14])=[CH:10][C:6]=1[C:7]([NH:15][C:16]1[S:17][CH:18]=[C:19]([C:21]([CH3:24])([CH3:23])[CH3:22])[N:20]=1)=[O:9])(=[O:3])[CH3:2]Komponenten
3
Versuchsvorschrift
Using 2-acetoxy-5-bromobenzoic acid and 2-amino-4-[(1,1-dimethyl)-ethyl]thiazole as the raw materials, the same operation as the example 24 gave the title compound.
Quellen und Nachweise
- ORD-Eintrag
- ord-f631ad856fe3418f9815d2001cea93cb
- Quelldatensatz
- uspto-grants-2012_01